Abstract:Mycobacterium tuberculosis (Mtb) is the key devastating bacterial pathogen responsible for tuberculosis. Increasing emergence of multi-drug-resistant, extensively drug-resistant, and rifampicin/isoniazid-resistant strains of Mtb makes the discovery of validated drug targets an urgent priority. As a vital translational component of the protein biosynthesis system, elongation factor Tu (EF-Tu) is an important molecular switch responsible for selection and binding of the cognate aminoacyl-tRNA to the acceptor site on the ribosome. In addition, EF-Tu from Mtb (MtbEF-Tu) is involved in the initial step of trans-translation which is an effective system for rescuing the stalled ribosomes from non-stop translation complexes under stress conditions. Given its crucial role in protein biosynthesis, EF-Tu is identified as an excellent molecular target for drug design. Here, we reported the recombinant expression, purification, biophysical characterization, and structural modeling of the MtbEF-Tu protein. Our results demonstrated that prokaryotic expression plasmids of pET28a-MtbEF-Tu could be expressed efficiently in Escherichia coli. We successfully purified the 6× His-tagged proteins with a yield of 16.8 mg from 1 l of Luria Bertani medium. Dynamic light scattering experiments showed that MtbEF-Tu existed in a monomeric form, and circular dichroism experiments indicated that MtbEF-Tu was well structured. Moreover, isothermal titration calorimetry experiments displayed that the purified MtbEF-Tu protein possessed intermediate binding affinities for guanosine-5'-triphosphate (GTP) and GDP. The GTP/GDP-binding sites were predicted by flexible molecular docking approach which reveals that GTP/GDP binds to MtbEF-Tu mainly through hydrogen bonds. Our work lays the essential basis for further structural and functional studies of MtbEF-Tu as well as MtbEF-Tu-related novel drug developments.

Structural insights of the elongation factor EF-Tu complexes in protein translation of Mycobacterium tuberculosis

Biophysical Characterization and Ligand-Binding Properties of the Elongation Factor Tu from Mycobacterium Tuberculosis.

Crystal Structure of Mycobacterium tuberculosis Elongation Factor G1

The Structural and Molecular Mechanisms of Mycobacterium tuberculosis Translational Elongation Factor Proteins

Structural Basis of Mycobacterium Tuberculosis Transcription and Transcription Inhibition

Cryo-EM Structure of Mycobacterium Tuberculosis 50S Ribosomal Subunit Bound with Clarithromycin Reveals Dynamic and Specific Interactions with Macrolides

Unlocking translational machinery for antitubercular drug development

Structural Insights into the Complex of Trigger Factor Chaperone and Ribosomal Protein S7 from Mycobacterium Tuberculosis.

Structural Basis for Ribosome Protein S1 Interaction with RNA in Trans -Translation of Mycobacterium Tuberculosis

Structural insights on Mycobacterium tuberculosis thiazole synthase--a molecular dynamics/docking approach

Protein targets for structure-based anti- Mycobacterium tuberculosis drug discovery

Structural Biology and Inhibition of the Mtb Cell Wall Glycoconjugates Biosynthesis on the Membrane

Structure-Based Screening and Optimization of PafA Inhibitors with Potent Anti-Tuberculosis Activity

Discovery and evaluation of new compounds targeting ribosomal protein S1 in antibiotic-resistant Mycobacterium Tuberculosis.

Structural Basis for the C-Terminal Domain of Mycobacterium Tuberculosis Ribosome Maturation Factor RimM to Bind Ribosomal Protein S19.

Protein Targets for Structure-Based Anti-Mycobacterium Tuberculosis Drug Discovery

Low-resolution SAXS and structural dynamics analysis on M. tuberculosis GmhB enzyme involved in GDP-heptose biosynthetic pathway

Structure of Mycobacterial Cytochrome Bcc in Complex with Q203 and TB47, Two Anti-Tb Drug Candidates

Structures of the Mycobacterium tuberculosis efflux pump EfpA reveal the mechanisms of transport and inhibition

Structure and inhibition mechanisms of Mycobacterium tuberculosis essential transporter efflux protein A

Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate